Literature DB >> 1991472

Mechanism of the inhibition of alpha-thrombin by hirudin-derived fragments hirudin(1-47) and hirudin(45-65).

T Schmitz1, M Rothe, J Dodt.   

Abstract

The kinetic mechanism of the inhibition of alpha-thrombin by hirudin was analyzed using the hirudin-derived fragments hirudin(1-47) and hirudin(45-65). Previously, these fragments have been shown to interact with alpha-thrombin at distinct sites inhibiting thrombin-mediated clot formation. Binding to the active site the N-terminal fragment hirudin(1-47) competitively inhibits hydrolysis of the substrates Tos-Gly-Pro-Arg-NH-Mec (Tos, tosyl; NH-Mec, 4-methylcoumaryl-7-amide) and fibrinogen with Ki values of 420 +/- 18 nM and 460 +/- 25 nM, respectively. Interacting with the anion-binding site of alpha-thrombin the C-terminal fragment competitively inhibits the hydrolysis of fibrinogen with a Ki of 760 +/- 40 nM. It was found, however, that this fragment acts as a hyperbolic uncompetitive inhibitor with respect to the hydrolysis of the peptide-NH-Mec substrate. According to the Botts-Morales scheme for enzyme inhibition, the parameters Ki = 710 +/- 38 nM, K'i = 348 +/- 22 nM, as well as alpha = beta = 0.49 of thrombin inhibition by the C-terminal fragment hirudin(45-65), were obtained. The results are discussed in terms of the interaction of hirudin and thrombin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1991472     DOI: 10.1111/j.1432-1033.1991.tb15701.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Phenomenological analysis of the clotting curve.

Authors:  R De Cristofaro; E Di Cera
Journal:  J Protein Chem       Date:  1991-10

2.  Hirudins of the Asian medicinal leech, Hirudinaria manillensis: same same, but different.

Authors:  Phil Lukas; Robert Wolf; Bernhard H Rauch; Jan-Peter Hildebrandt; Christian Müller
Journal:  Parasitol Res       Date:  2019-06-11       Impact factor: 2.289

3.  The thrombin E192Q-BPTI complex reveals gross structural rearrangements: implications for the interaction with antithrombin and thrombomodulin.

Authors:  A van de Locht; W Bode; R Huber; B F Le Bonniec; S R Stone; C T Esmon; M T Stubbs
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

4.  Evidence for common structural changes in thrombin induced by active-site or exosite binding.

Authors:  M A Parry; S R Stone; J Hofsteenge; M P Jackman
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

5.  Effect of temperature on the association step in thrombin-fibrinogen interaction.

Authors:  M Picozzi; R De Cristofaro
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

6.  Heparin enhances the catalytic activity of des-ETW-thrombin.

Authors:  C A Goodwin; J J Deadman; B F Le Bonniec; S Elgendy; V V Kakkar; M F Scully
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

7.  The linkage between binding of the C-terminal domain of hirudin and amidase activity in human alpha-thrombin.

Authors:  R de Cristofaro; B Rocca; B Bizzi; R Landolfi
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

8.  Screening of the Promising Direct Thrombin Inhibitors from Haematophagous Organisms. Part I: Recombinant Analogues and Their Antithrombotic Activity In Vitro.

Authors:  Maria A Kostromina; Elena A Tukhovskaya; Elvira R Shaykhutdinova; Gulsara A Slashcheva; Alina M Ismailova; Victor A Palikov; Yuliya A Palikova; Igor A Dyachenko; Irina N Kravchenko; Elena S Sadovnikova; Nadezhda I Novikova; Natalia A Perepechenova; Evgeniy A Zayats; Yuliya A Abramchik; Dmitry D Lykoshin; Andrey N Mamaev; Elena V Grigorieva; Andrey P Momot; Arkady N Murashev; Roman S Esipov
Journal:  Biomedicines       Date:  2021-12-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.